DNA demethylation and cancer: Therapeutic implications

Cancer Letters

Volumn 211, Issue 2, 2004, Pages 133-143

  Szyf, Moshe ^a   Pakneshan, Pouya ^a   Rabbani, Shafaat A ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Demethylase; DNA methylation; Epigenome; Global hypomethylation; Histone modification; Histones; Metastasis

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ANTINEOPLASTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; AZACITIDINE; DNA; DNA METHYLTRANSFERASE; ENZYME INHIBITOR; PROTEIN;

BREAST CANCER; CANCER; CANCER GENETICS; CANCER INVASION; CARCINOGENESIS; CHROMATIN; CLINICAL TRIAL; DEMETHYLATION; DNA METHYLATION; DRUG TARGETING; GENE ACTIVATION; GENE EXPRESSION; HUMAN; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; SHORT SURVEY; TUMOR SUPPRESSOR GENE;

EID: 3042658499     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.04.009     Document Type: Review

References (103)

1. Strahl B.D., Allis C.D. The language of covalent histone modifications. Nature. 403:2000;41-45
2. Jenuwein T., Allis C.D. Translating the histone code. Science. 293:2001;1074-1080
3. Jenuwein T. Re-SET-ting heterochromatin by histone methyltransferases. Trends Cell Biol. 11:2001;266-273
4. Wade P.A., Wolffe A.P. Histone acetyltransferases in control. Curr. Biol. 7:1997;R82-R84
5. Kuo M.H., Allis C.D. Roles of histone acetyltransferases and deacetylases in gene regulation. Bioessays. 20:1998;615-626
6. Tsukiyama T., Wu C. Chromatin remodeling and transcription. Curr. Opin. Genet. Dev. 7:1997;182-191
7. Razin A., Riggs A.D. DNA methylation and gene function. Science. 210:1980;604-610
8. Araujo F.D., Knox J.D., Szyf M., Price G.B., Zannis-Hadjopoulos M. Concurrent replication and methylation at mammalian origins of replication [published erratum appears in Mol Cell Biol, 1999 Jun;19(6):4546]. Mol. Cell. Biol. 18:1998;3475-3482
9. Robert M.F., Morin S., Beaulieu N., Gauthier F., Chute I.C., Barsalou A., MacLeod A.R. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells. Nat. Genet. 33:2003;61-65
10. Hansen R.S., Wijmenga C., Luo P., Stanek A.M., Canfield T.K., Weemaes C.M., Gartler S.M. The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome. Proc. Natl Acad. Sci. USA. 96:1999;14412-14417
11. Okano M., Bell D.W., Haber D.A., Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell. 99:1999;247-257
12. Liang G., Chan M.F., Tomigahara Y., Tsai Y.C., Gonzales F.A., Li E., et al. Cooperativity between DNA methyltransferases in the maintenance methylation of repetitive elements. Mol. Cell. Biol. 22:2002;480-491
13. Chen T., Ueda Y., Dodge J.E., Wang Z., Li E. Establishment and maintenance of genomic methylation patterns in mouse embryonic stem cells by Dnmt3a and Dnmt3b. Mol. Cell. Biol. 23:2003;5594-5605
14. Razin A., Szyf M. DNA methylation patterns. Formation and function. Biochim. Biophys. Acta. 782:1984;331-342
15. Ramchandani S., Bhattacharya S.K., Cervoni N., Szyf M. DNA methylation is a reversible biological signal [see comments]. Proc. Natl Acad. Sci. USA. 96:1999;6107-6112
16. Szyf M. Towards a pharmacology of DNA methylation. Trends Pharmacol. Sci. 22:2001;350-354
17. Razin A. CpG methylation, chromatin structure and gene silencing-a three-way connection. Eur. Mol. Biol. Org. J. 17:1998;4905-4908
18. Razin A., Cedar H. Distribution of 5-methylcytosine in chromatin. Proc. Natl Acad. Sci. USA. 74:1977;2725-2728
19. Nan X., Ng H.H., Johnson C.A., Laherty C.D., Turner B.M., Eisenman R.N., Bird A. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex [see comments]. Nature. 393:1998;386-389
20. Jones P.L., Veenstra G.J., Wade P.A., Vermaak D., Kass S.U., Landsberger N., et al. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat. Genet. 19:1998;187-191
21. Bachman K.E., Park B.H., Rhee I., Rajagopalan H., Herman J.G., Baylin S.B., et al. Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene. Cancer Cell. 3:2003;89-95
22. Cervoni N., Szyf M. Demethylase activity is directed by histone acetylation. J. Biol. Chem. 276:2001;40778-40787
23. Cervoni N., Detich N., Seo S.B., Chakravarti D., Szyf M. The oncoprotein Set/TAF-1beta, an inhibitor of histone acetyltransferase, inhibits active demethylation of DNA, integrating DNA methylation and transcriptional silencing. J. Biol. Chem. 277:2002;25026-25031
24. Baylin S.B., Hoppener J.W., de Bustros A., Steenbergh P.H., Lips C.J., Nelkin B.D. DNA methylation patterns of the calcitonin gene in human lung cancers and lymphomas. Cancer Res. 46:1986;2917-2922
25. Baylin S.B. Abnormal regional hypermethylation in cancer cells. AIDS Res. Hum. Retroviruses. 8:1992;811-820
26. Herman J.G., Baylin S.B. Promoter-region hypermethylation and gene silencing in human cancer. Curr. Top. Microbiol. Immunol. 249:2000;35-54
27. Feinberg A.P., Vogelstein B. Alterations in DNA methylation in human colon neoplasia. Semin. Surg. Oncol. 3:1987;149-151
28. Ehrlich M. DNA methylation in cancer: too much, but also too little. Oncogene. 21:2002;5400-5413
29. Sherr C.J. Principles of tumor suppression. Cell. 116:2004;235-246
30. Feinberg A.P., Tycko B. The history of cancer epigenetics. Nat. Rev. Cancer. 4:2004;143-153
31. Esteller M., Sparks A., Toyota M., Sanchez-Cespedes M., Capella G., Peinado M.A., et al. Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer [in process citation]. Cancer Res. 60:2000;4366-4371
32. Baylin S.B., Esteller M., Rountree M.R., Bachman K.E., Schuebel K., Herman J.G. Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum. Mol. Genet. 10:2001;687-692
33. Paz M.F., Fraga M.F., Avila S., Guo M., Pollan M., Herman J.G., Esteller M. A systematic profile of DNA methylation in human cancer cell lines. Cancer Res. 63:2003;1114-1121
34. Huang T.H., Perry M.R., Laux D.E. Methylation profiling of CpG islands in human breast cancer cells. Hum. Mol. Genet. 8:1999;459-470
35. Shi H., Maier S., Nimmrich I., Yan P.S., Caldwell C.W., Olek A., Huang T.H. Oligonucleotide-based microarray for DNA methylation analysis: principles and applications. J. Cell. Biochem. 88:2003;138-143
36. Yan P.S., Perry M.R., Laux D.E., Asare A.L., Caldwell C.W., Huang T.H. CpG island arrays: an application toward deciphering epigenetic signatures of breast cancer. Clin. Cancer Res. 6:2000;1432-1438
37. Palmisano W.A., Divine K.K., Saccomanno G., Gilliland F.D., Baylin S.B., Herman J.G., Belinsky S.A. Predicting lung cancer by detecting aberrant promoter methylation in sputum [in process citation]. Cancer Res. 60:2000;5954-5958. In Process Citation
38. Herman J.G., Graff J.R., Myohanen S., Nelkin B.D., Baylin S.B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl Acad. Sci. USA. 93:1996;9821-9826
39. Szyf M. DNA methylation properties: consequences for pharmacology. Trends Pharmacol. Sci. 15:1994;233-238
40. Szyf M. The DNA methylation machinery as a target for anticancer therapy. Pharmacol. Ther. 70:1996;1-37
41. Jones P.A. Altering gene expression with 5-azacytidine. Cell. 40:1985;485-486
42. Merlo A., Herman J.G., Mao L., Lee D.J., Gabrielson E., Burger P.C., et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat. Med. 1:1995;686-692
43. Fournel M., Sapieha P., Beaulieu N., Besterman J.M., MacLeod A.R. Down-regulation of human DNA-(cytosine-5) methyltransferase induces cell cycle regulators p16(ink4A) and p21(WAF/Cip1) by distinct mechanisms. J. Biol. Chem. 274:1999;24250-24256
44. MacLeod A.R., Szyf M. Expression of antisense to DNA methyltransferase mRNA induces DNA demethylation and inhibits tumorigenesis. J. Biol. Chem. 270:1995;8037-8043
45. Ramchandani S., MacLeod A.R., Pinard M., von Hofe E., Szyf M. Inhibition of tumorigenesis by a cytosine-DNA, methyltransferase, antisense oligodeoxynucleotide. Proc. Natl Acad. Sci. USA. 94:1997;684-689
46. Goffin J., Eisenhauer E. DNA methyltransferase inhibitors - state of the art. Ann. Oncol. 13:2002;1699-1716
47. Zhang S., Qian X., Redman C., Bliskovski V., Ramsay E.S., Lowy D.R., Mock B.A. p16 INK4a gene promoter variation and differential binding of a repressor, the ras-responsive zinc-finger transcription factor, RREB. Oncogene. 22:2003;2285-2295
48. Fuks F., Burgers W.A., Brehm A., Hughes-Davies L., Kouzarides T. DNA methyltransferase Dnmt1 associates with histone deacetylase activity. Nat. Genet. 24:2000;88-91
49. Fuks F., Burgers W.A., Godin N., Kasai M., Kouzarides T. Dnmt3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcription. Eur. Mol. Biol. Org. J. 20:2001;2536-2544
50. Fuks F., Hurd P.J., Deplus R., Kouzarides T. The DNA methyltransferases associate with HP1 and the SUV39H1 histone methyltransferase. Nucleic Acids Res. 31:2003;2305-2312
51. Di Croce L., Raker V.A., Corsaro M., Fazi F., Fanelli M., Faretta M., et al. Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor. Science. 295:2002;1079-1082
52. Robertson K.D., Ait-Si-Ali S., Yokochi T., Wade P.A., Jones P.L., Wolffe A.P. DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters. Nat. Genet. 25:2000;338-342
53. Szyf M., Knox D.J., Milutinovic S., Slack A.D., Araujo F.D. How does DNA methyltransferase cause oncogenic transformation? Ann. N. Y. Acad. Sci. 910:2000;156-174. discussion 157-175
54. Milutinovic S., Brown S.E., Zhuang Q., Szyf M. DNMT1 knock down induces gene expression by a mechanism independent of the two epigenetic silencing mechanisms: DNA methylation and histone deacetylation. J. Biol. Chem. 2004
55. Milutinovic S., Zhuang Q., Niveleau A., Szyf M. Epigenomic stress response. Knockdown of DNA methyltransferase 1 triggers an intra-S-phase arrest of DNA replication and induction of stress response genes. J. Biol. Chem. 278:2003;14985-14995
56. Milutinovic S., Knox J.D., Szyf M., methyltransferase D.N.A. inhibition induces the transcription of the tumor suppressor p21(WAF1/CIP1/sdi1). J. Biol. Chem. 275:2000;6353-6359
57. Szyf M. Targeting DNA methylation in cancer. Ageing Res. Rev. 2:2003;299-328
58. Feinberg A.P., Gehrke C.W., Kuo K.C., Ehrlich M. Reduced genomic 5-methylcytosine content in human colonic neoplasia. Cancer Res. 48:1988;1159-1161
59. Ji W., Hernandez R., Zhang X.Y., Qu G.Z., Frady A., Varela M., Ehrlich M. DNA demethylation and pericentromeric rearrangements of chromosome 1. Mutat. Res. 379:1997;33-41
60. Qu G., Dubeau L., Narayan A., Yu M.C., Ehrlich M. Satellite DNA hypomethylation vs. overall genomic hypomethylation in ovarian epithelial tumors of different malignant potential. Mutat. Res. 423:1999;91-101
61. Cheah M.S., Wallace C.D., Hoffman R.M. Hypomethylation of DNA in human cancer cells: a site-specific change in the c-myc oncogene. J. Natl Cancer Inst. 73:1984;1057-1065
62. Kaneko Y., Shibuya M., Nakayama T., Hayashida N., Toda G., Endo Y., et al. Hypomethylation of c-myc and epidermal growth factor receptor genes in human hepatocellular carcinoma and fetal liver. Jpn. J. Cancer Res. 76:1985;1136-1140
63. Bhave M.R., Wilson M.J., Poirier L.A. c-H-ras and c-K-ras gene hypomethylation in the livers and hepatomas of rats fed methyl-deficient, amino acid-defined diets. Carcinogenesis. 9:1988;343-348
64. Lipsanen V., Leinonen P., Alhonen L., Janne J. Hypomethylation of ornithine decarboxylase gene and erb-A1 oncogene in human chronic lymphatic leukemia. Blood. 72:1988;2042-2044
65. Chen R.Z., Pettersson U., Beard C., Jackson-Grusby L., Jaenisch R. DNA hypomethylation leads to elevated mutation rates. Nature. 395:1998;89-93
66. Lu L.J., Randerath K. Long term instability and molecular mechanism of 5-azacytidine-induced DNA hypomethylation in normal and neoplastic tissues in vivo. Mol. Pharmacol. 26:1984;594-603
67. Pakneshan P., Xing R.H., Rabbani S.A. Methylation status of uPA promoter as a molecular mechanism regulating prostate cancer invasion and growth in vitro and in vivo. Fed. Am. Soc. Exp. Biol. J. 17:2003;1081-1088
68. Guo Y., Pakneshan P., Gladu J., Slack A., Szyf M., Rabbani S.A. Regulation of DNA methylation in human breast cancer. Effect on the urokinase-type plasminogen activator gene production and tumor invasion. J. Biol. Chem. 277:2002;41571-41579
69. el-Deiry W.S., Nelkin B.D., Celano P., Yen R.W., Falco J.P., Hamilton S.R., Baylin S.B. High expression of the DNA methyltransferase gene characterizes human neoplastic cells and progression stages of colon cancer. Proc. Natl Acad. Sci. USA. 88:1991;3470-3474
70. Nass S.J., Ferguson A.T., El-Ashry D., Nelson W.G., Davidson N.E. Expression of DNA methyl-transferase (DMT) and the cell cycle in human breast cancer cells. Oncogene. 18:1999;7453-7461
71. De Marzo A.M., Marchi V.L., Yang E.S., Veeraswamy R., Lin X., Nelson W.G. Abnormal regulation of DNA methyltransferase expression during colorectal carcinogenesis. Cancer Res. 59:1999;3855-3860
72. Szyf M. DNA methylation and cancer therapy. Drug Resist. Updat. 6:2003;341-353
73. Nakamura N., Takenaga K. Hypomethylation of the metastasis-associated S100A4 gene correlates with gene activation in human colon adenocarcinoma cell lines. Clin. Exp. Metastasis. 16:1998;471-479
74. Rosty C., Ueki T., Argani P., Jansen M., Yeo C.J., Cameron J.L., et al. Overexpression of S100A4 in pancreatic ductal adenocarcinomas is associated with poor differentiation and DNA hypomethylation. Am. J. Pathol. 160:2002;45-50
75. Shteper P.J., Zcharia E., Ashhab Y., Peretz T., Vlodavsky I., Ben-Yehuda D. Role of promoter methylation in regulation of the mammalian heparanase gene. Oncogene. 22:2003;7737-7749
76. De Smet C., De Backer O., Faraoni I., Lurquin C., Brasseur F., Boon T. The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. Proc. Natl Acad. Sci. USA. 93:1996;7149-7153
77. Wascher R.A., Bostick P.J., Huynh K.T., Turner R., Qi K., Giuliano A.E., Hoon D.S. Detection of MAGE-A3 in breast cancer patients' sentinel lymph nodes. Br. J. Cancer. 85:2001;1340-1346
78. Taback B., Chan A.D., Kuo C.T., Bostick P.J., Wang H.J., Giuliano A.E., Hoon D.S. Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease. Cancer Res. 61:2001;8845-8850
79. Habets G.G., van der Kammen R.A., Scholtes E.H., Collard J.G. Induction of invasive and metastatic potential in mouse T-lymphoma cells (BW5147) by treatment with 5-azacytidine. Clin. Exp. Metastasis. 8:1990;567-577
80. Takenaga K. Modification of the metastatic potential of tumor cells by drugs. Cancer Metastasis Rev. 5:1986;67-75
81. Olsson L., Forchhammer J. Induction of the metastatic phenotype in a mouse tumor model by 5-azacytidine, and characterization of an antigen associated with metastatic activity. Proc. Natl Acad. Sci. USA. 81:1984;3389-3393
82. Ehrlich M. The ICF syndrome, a DNA methyltransferase 3B deficiency and immunodeficiency disease. Clin. Immunol. 109:2003;17-28
83. Hernandez R., Frady A., Zhang X.Y., Varela M., Ehrlich M. Preferential induction of chromosome 1 multibranched figures and whole-arm deletions in a human pro-B cell line treated with 5-azacytidine or 5-azadeoxycytidine. Cytogenet. Cell Genet. 76:1997;196-201
84. Zimmermann F.K., Scheel I. Genetic effects of 5-azacytidine in Saccharomyces cerevisiae. Mutat. Res. 139:1984;21-24
85. Wilson M.J., Shivapurkar N., Poirier L.A. Hypomethylation of hepatic nuclear DNA in rats fed with a carcinogenic methyl-deficient diet. Biochem. J. 218:1984;987-990
86. Kanduc D., Ghoshal A., Quagliariello E., Farber E. DNA hypomethylation in ethionine-induced rat preneoplastic hepatocyte nodules. Biochem. Biophys. Res. Commun. 150:1988;739-744
87. Pascale R.M., Simile M.M., De Miglio M.R., Feo F. Chemoprevention of hepatocarcinogenesis: S-adenosyl-L-methionine. Alcohol. 27:2002;193-198
88. Giovannucci E., Stampfer M.J., Colditz G.A., Rimm E.B., Trichopoulos D., Rosner B.A., et al. Folate, methionine, and alcohol intake and risk of colorectal adenoma. J. Natl Cancer Inst. 85:1993;875-884
89. Potter J.D. Methyl supply, methyl metabolizing enzymes and colorectal neoplasia. J. Nutr. 132:2002;2410S-2412S
90. Ryan B.M., Weir D.G. Relevance of folate metabolism in the pathogenesis of colorectal cancer. J. Lab. Clin. Med. 138:2001;164-176
91. Lu S.C., Huang Z.Z., Yang H., Mato J.M., Avila M.A., Tsukamoto H. Changes in methionine adenosyltransferase and S-adenosylmethionine homeostasis in alcoholic rat liver. Am. J. Physiol. Gastrointest. Liver Physiol. 279:2000;G178-G185
92. Shannon B., Gnanasampanthan S., Beilby J., Iacopetta B. A polymorphism in the methylenetetrahydrofolate reductase gene predisposes to colorectal cancers with microsatellite instability. Gut. 50:2002;520-524
93. Heijmans B.T., Boer J.M., Suchiman H.E., Cornelisse C.J., Westendorp R.G., Kromhout D., et al. A common variant of the methylenetetrahydrofolate reductase gene (1p36) is associated with an increased risk of cancer. Cancer Res. 63:2003;1249-1253
94. Semenza J.C., Delfino R.J., Ziogas A., Anton-Culver H. Breast cancer risk and methylenetetrahydrofolate reductase polymorphism. Breast Cancer Res. Treat. 77:2003;217-223
95. Lambropoulos A.F., Agorastos T., Foka Z.J., Chrisafi S., Constantinidis T.C., Bontis J., Kotsis A. Methylenetetrahydrofolate reductase polymorphism C677T is not associated to the risk of cervical dysplasia. Cancer Lett. 191:2003;187-191
96. Langsenlehner U., Krippl P., Renner W., Yazdani-Biuki B., Wolf G., Wascher T.C., et al. The common 677C>T gene polymorphism of methylenetetrahydrofolate reductase gene is not associated with breast cancer risk. Breast Cancer Res. Treat. 81:2003;169-172
97. Gaudet F., Hodgson J.G., Eden A., Jackson-Grusby L., Dausman J., Gray J.W., et al. Induction of tumors in mice by genomic hypomethylation. Science. 300:2003;489-492
98. Detich N., Hamm S., Just G., Knox J.D., Szyf M. The methyl donor S-adenosylmethionine inhibits active demethylation of DNA: a candidate novel mechanism for the pharmacological effects of S-adenosylmethionine. J. Biol. Chem. 278:2003;20812-20820
99. Bhattacharya S.K., Ramchandani S., Cervoni N., Szyf M. A mammalian protein with specific demethylase activity for mCpG DNA [see comments]. Nature. 397:1999;579-583
100. Ng H.H., Zhang Y., Hendrich B., Johnson C.A., Turner B.M., Erdjument-Bromage H., et al. MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex [see comments]. Nat. Genet. 23:1999;58-61
101. Zhang Y., Ng H.H., Erdjument-Bromage H., Tempst P., Bird A., Reinberg D. Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev. 13:1999;1924-1935
102. Detich N., Theberge J., Szyf M. Promoter-specific activation and demethylation by MBD2/demethylase. J. Biol. Chem. 277:2002;35791-35794
103. Detich N., Bovenzi V., Szyf M. Valproate induces replication-independent active DNA demethylation. J. Biol. Chem. 278:2003;27586-27592